Navigation Links
SI-BONE Announces Global Clinical Strategy for Minimally Invasive iFuse Sacroiliac Joint Fusion
Date:8/1/2011

'failed back surgery' patients.(1) Effective treatment of the SI joint is a significant unmet clinical need and, when conservative therapy fails, iFuse may provide an option.

In response to increasing awareness of SI joint disruption and dysfunction as debilitating symptom generators, SI-BONE, Inc. developed an innovative, patented, intramedullary implant to treat the SI joint. The company is also embarking on a prospective multicenter study to document acute and long-term clinical outcomes in patients who are proven to be refractory to prior therapies.

The iFuse Implant System is a commercially available device in the U.S. intended for treatment of conditions including sacroiliac joint disruptions and degenerative sacroiliitis. The iFuse procedure uses a minimal incision for delivery and implantation of small, titanium implants.  The implants are coated with a porous plasma spray that acts as an interference surface, designed to help decrease implant motion.  These implants have substantial thickness and sophisticated metallurgy and are able to produce a much stronger construct than that of conventional pins or screws used to surgically fix boney structures.  This implant technology from SI-BONE has been previously used successfully in well over 1,500 cases of dysfunctional foot joints.

About SI-BONE, Inc.

SI-BONE, Inc. (San Jose, California) is the leading sacroiliac joint spine medical device company dedicated to the development of tools and products for diagnosing and treating patients with low back issues related to sacroiliac (SI) joint pathology.  The company has developed, and is manufacturing and marketing, less invasive approaches using implants for the treatment of SI Joint pathology.  SI-BONE has an experienced management team with extensive experience in orthopedic and spine medical devices.

(1) DePalma, M. Etiology of chronic LBP patients having undergone lumbar fusion. Pain Medici
'/>"/>

SOURCE SI-BONE, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Over 400 Surgeons Trained by SI-BONE to Perform Minimally Invasive iFuse Sacroiliac Joint Fusion
2. SI-BONE Adds Texas Back Institute Founder to Its Medical Advisory Board
3. SI-BONE, Inc. Closes $11.0 Million Financing Led by Skyline Ventures
4. Frank Phillips, Paul Anderson and Federico Girardi Join SI-BONEs Medical Advisory Board
5. Hologic Announces Third Quarter Fiscal 2011 Operating Results
6. Medela Announces 2011 Breastfeeding Hall of Excellence Inductees to Nationally Recognize Exceptional Breastfeeding Advocates
7. Misonix Announces New Distribution Agreement for Chile
8. Kensey Nash Corporation Announces Its Fourth Quarter and Fiscal Year End 2011 Earnings Release Date and Teleconference
9. Omnicell Announces Second Quarter 2011 Results
10. BioMarin Announces Second Quarter 2011 Financial Results
11. McNeil Consumer Healthcare Announces Plans for New Dosing Instructions for TYLENOL® Products
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)...  According to Millennium Research Group (MRG), the global ... the United States and European transcatheter ... moderately through 2022, with embolization particles representing one ... in drug-eluting beads (DEBs) and radioembolization spheres in ...
(Date:1/15/2014)... , Jan. 15, 2014 ... research report is available in its ... Markets and Technologies for Advanced Drug ... of Administration ...
(Date:1/14/2014)... InformEx, North America,s leading business ... hold the 30 th edition of its annual conference ... from January 21-24. (Logo: http://photos.prnewswire.com/prnh/20131028/NY05330LOGO-a ) ... chemical and specialty chemical companies will take part in the ...
Breaking Medicine Technology:US and European Transcatheter Embolization and Occlusion Device Market to Surpass $1.6 Billion by 2022 2US and European Transcatheter Embolization and Occlusion Device Market to Surpass $1.6 Billion by 2022 3Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 2Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 3Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 4Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 5Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 6Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 7Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 8Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 9Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 10Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 11Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 12Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 13Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 14Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 15Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 16Media Advisory: InformEx 2014 Events & Speaker Lineup for 30th Edition Conference in Miami Beach 2
(Date:4/17/2014)... led by researchers at UC Davis has shown that ... role in cell division, also boosts the mitochondrial activity ... the complex has been shown to perform both jobs. ... target to control cellular energy production, potentially advancing cancer ... today in the journal Developmental Cell . , ...
(Date:4/17/2014)... international research team led by Cesar A. Arias, M.D., ... at Houston (UTHealth) has identified a new superbug that ... report appeared in the April 17 issue of ... new superbug is part of a class of highly-resistant ... MRSA, which is a major cause of hospital and ...
(Date:4/17/2014)... not uncommon these days to find a colored ribbon representing ... breast cancer. But what color ribbon does one think of ... designated color, for many suffering from the disease, black may ... University study consisting of lung cancer patients, primarily smokers between ... more light on the stigma often felt by these patients, ...
(Date:4/17/2014)... therapy improves general blood flow and alleviates muscle ... researchers at the University of Illinois at Chicago. ... print in the Archives of Physical Medicine ... vascular function in people who had not exercised, ... of their level of physical activity. , Improved ...
(Date:4/17/2014)... shocking rates of suicide are highest in areas with ... smallholdings less than one hectare and trying ... that are highly susceptible to global price fluctuations. , ... that point to a crisis in key areas of ... economy during the 90s. Researchers say that policy intervention ...
Breaking Medicine News(10 mins):Health News:Dual role: Key cell division proteins also power up mitochondria 2Health News:New MRSA superbug emerges in Brazil 2Health News:Unraveling the 'black ribbon' around lung cancer 2Health News:Massage therapy improves circulation, eases muscle soreness 2Health News:New evidence of suicide epidemic among India's 'marginalized' farmers 2Health News:New evidence of suicide epidemic among India's 'marginalized' farmers 3
... the world's leading manufacturer and distributor of automated ... have its newest health station, the LC600 at ... be held at the Venetian Resort, Las Vegas, ... will be located in the Pharmacy of the ...
... July 3 The following is the,National Council ... The Bulletin, which is free of charge and ... you the latest issues and news affecting people ... to, http://listserv.access.gpo.gov, click on Online mailing list ...
... successfully introduced by P.-I. Brnemark and co-workers in ... years of research and development, titanium is currently ... titanium-based materials are often used to replace lost ... are some alternatives to modulating the body,s response ...
... Group, Inc. (MED3OOO), a,national leader in healthcare management ... has entered into a partnership,arrangement with Mitsui & ... & Co., Ltd. (Mitsui). The agreement with Mitsui ... of being a global "premier,strategic operations partner" for ...
... SAN FRANCISCO, Calif., July 3 Sunesis,Pharmaceuticals, Inc. (Nasdaq: ... Executive Officer and President, will provide a corporate,overview at ... p.m. Eastern Time on July 8, 2008 in New ... of the presentation by visiting,the Sunesis website at ...
... Therapeutics Inc.,("Transition" or the "Company") (TSX: TTH; NASDAQ: ... is pleased to announce that Mr. Elie,Farah has ... serve as,Chief Financial Officer, and Ms. Nicole Rusaw-George ... "These promotions reflect the strength of our ...
Cached Medicine News:Health News:Lifeclinic to Feature Latest Health Stations at McKesson's Pharmacy of the Future 2Health News:Lifeclinic to Feature Latest Health Stations at McKesson's Pharmacy of the Future 3Health News:Lifeclinic to Feature Latest Health Stations at McKesson's Pharmacy of the Future 4Health News:National Council on Disability Monthly Bulletin for June, 2008 2Health News:National Council on Disability Monthly Bulletin for June, 2008 3Health News:National Council on Disability Monthly Bulletin for June, 2008 4Health News:National Council on Disability Monthly Bulletin for June, 2008 5Health News:MED3OOO and Mitsui & Co. Complete U.S. and Global Healthcare Partnership Agreement 2Health News:MED3OOO and Mitsui & Co. Complete U.S. and Global Healthcare Partnership Agreement 3Health News:Transition Therapeutics Announces Executive Management Appointments 2
... Finnpipette Focus from Thermo Labsystems was designed ... Advanced features such as the new ... adjustment on microvolumes help to define this ... pipettes. The new interchangeable handle plate offers ...
This unique kit contains three pipettes conveniently packaged with useful accessoriesat an economical price....
... immunochromatography based one step in vitro test. ... and its metabolite in human urine,specimens. The ... a cut-off level of 300 ng/mL,can be ... in the point of care location and ...
... unique kit contains three pipettes ... an economical price. Three classic ... Two racks of certified-quality Diamond ... adhesive-backed Single Pipette Hangers 10 ...
Medicine Products: